Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations

Metabolic Brain Disease

Volumn 28, Issue 2, 2013, Pages 151-154

  Llansola, Marta ^a   Montoliu, Carmina ^b   Cauli, Omar ^a   Hernández Rabaza, Vicente ^a   Agustí, Ana ^a   Cabrera Pastor, Andrea ^a   Giménez Garzó, Carla ^a   González Usano, Alba ^a   Felipo, Vicente ^a  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Hepatic encephalopathy; Hyperammonemia; Learning; mGluRs; Motor function; NMDA receptor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; AMPA RECEPTOR; CYCLIC GMP; IBUPROFEN; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHODIESTERASE V INHIBITOR; GLUTAMIC ACID;

COGNITIVE DEFECT; CONFERENCE PAPER; HEPATIC ENCEPHALOPATHY; HIPPOCAMPUS POTENTIAL; HYPERAMMONEMIA; HYPOKINESIA; IN VIVO STUDY; LOCOMOTION; LONG TERM POTENTIATION; MOTOR ACTIVITY; MOTOR PERFORMANCE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PORTOCAVAL SHUNT; PREFRONTAL CORTEX; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS RETICULATA; ANIMAL; CHRONIC DISEASE; COGNITION DISORDERS; COMPLICATION; HUMAN; NERVOUS SYSTEM DISEASES; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

RATTUS;

ANIMALS; CHRONIC DISEASE; COGNITION DISORDERS; GLUTAMIC ACID; HUMANS; HYPERAMMONEMIA; NERVOUS SYSTEM DISEASES; SYNAPTIC TRANSMISSION;

EID: 84878012465     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-012-9337-3     Document Type: Conference Paper

References (27)

1. Agusti A, Cauli O, Rodrigo R, Llansola M, Hernández-Rabaza V, Felipo V (2011) p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 60(11):1572-1579
2. Boix J, Llansola M, Cabrera-Pastor A, Felipo V (2011) Metabotropic glutamate receptor 5 modulates the nitric oxide-cGMP pathway in cerebellum in vivo through activation of AMPA receptors. Neurochem Int 58(5):599-604
3. Cabrera-Pastor A, Llansola M, Reznikov V, Boix J, Felipo V (2012) Differential effects of chronic hyperammonemia on modulation of the glutamate-nitric oxide-cGMP pathway by metabotropic glutamate receptor 5 and low and high affinity AMPA receptors in cerebellum in vivo. Neurochem Int 61(1):63-71
4. Canales JJ, Elayadi A, Errami M, Llansola M, Cauli O, Felipo V (2003) Chronic hyperammonemia alters motor and neurochemical responses to activation of group I metabotropic glutamate receptors in the nucleus accumbens in rats in vivo. Neurobiol Dis 14:380-390
5. Cauli O, Llansola M, Erceg S, Felipo V (2006) Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra. J Hepatol 45:654-661
6. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V (2007a) Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with porto-caval shunts. Hepatology 46:514-519
7. Cauli O, Mlili N, Rodrigo R, Felipo V (2007b) Hyperammonemia alters the mechanisms by which metabotropic glutamate receptors in nucleus accumbens modulate motor function. J Neurochem 103(1):38-46
8. Cauli O, Mlili N, Llansola M, Felipo V (2007c) Motor activity is modulated via different neuronal circuits in rats with chronic liver failure than in normal rats. Eur J Neurosci 25:2112-2122
9. Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita BE, Mlili N, Boix J, Agustí A, Felipo V (2009a) Glutamatergic and GABAergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24:69-80
10. Cauli O, Mansouri MT, Agusti A, Felipo V (2009b) Hyperammonemia increases GABAergic tone in cerebellum but decreases it in rat cortex. Gastroenterology 136(4):1359-1367
11. Corbalán R, Chatauret N, Behrends S, Butterworth RF, Felipo V (2002) Region selective alterations of soluble guanylate cyclase content and modulation in brain of cirrhotic patients. Hepatology 36:1155-1162
12. ElMlili N, Boix J, Ahabrach H, Rodrigo R, Errami M, Felipo V (2010) Chronic hyperammonemia induces tonic activation of NMDA receptors in cerebellum. J Neurochem 112(4):1005-1014
13. El-Mlili N, Rodrigo R, Naghizadeh B, Cauli O, Felipo V (2008) Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium-calmodulin kinase II. J Neurochem 106(3):1440-1449
14. Erceg S, Monfort P, Hernández-Viadel M, Rodrigo R, Montoliu C, Felipo V (2005a) Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunt. Hepatology 45:2-10
15. Erceg S, Monfort P, Hernandez-Viadel M, Llansola M, Montoliu C, Felipo V (2005b) Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain. Brain Res 1036:115-121
16. Felipo V (2006) Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. World J Gastroenterol 12:7737-7743
17. Felipo V (2008) Hyperammonemia. Handbook of neurochemistry and molecular neurobiology. In: Lajtha A (ed) Hyperammonemia. Handbook of neurochemistry and molecular neurobiology. vol 24, 3rd edn. Kluwer Academic/Plenum Publishers, U.S.A, pp 1-27
18. Felipo V, Hermenegildo C, Montoliu C, Llansola M, Miñana MD (1998) Neurotoxicity of ammonia and glutamate: molecular mechanisms and prevention. Neurotoxicology 19(4-5):675-681
19. Hermenegildo C, Montoliu C, Llansola M, Muñoz MD, Gaztelu JM, Miñana MD, Felipo V (1998) Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo. Eur J Neurosci 10(10):3201-3209
20. Llansola M, Erceg S, Felipo V (2005) Chronic exposure to ammonia alters the modulation of phosphorylation of microtubule-aasociated protein MAP-2 by metabotropic glutamate receptors 1 and 5 in cerebellar neurons in culture. Neuroscience 133(1):185-191
21. Monfort P, Muñoz MD, ElAyadi A, Kosenko E, Felipo V (2002a) Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis 17(4):237-250
22. Monfort P, Kosenko E, Erceg S, Canales JJ, Felipo V (2002b) Molecular mechanism of acute ammonia toxicity: role of NMDA receptors. Neurochem Int 41(2-3):95-102
23. Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V (2009) Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy. Therapeutical implications. Neurochem Int 55:106-112
24. Montoliu C, Rodrigo R, Monfort P, Llansola M, Cauli O, Boix J, ElMlili N, Agusti A, Felipo V (2010) Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis 25:39-48
25. Muñoz MD, Monfort P, Gaztelu JM, Felipo V (2000) Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro. Neurochem Res 25(4):437-441
26. Rodrigo R, Erceg S, Felipo V (2005) Neurons exposed to ammonia reproduce the differential alteration in nitric oxide modulation of guanylate cyclase in cerebellum and cortex of patients with liver cirrhosis. Neurobiol Dis 19:150-161
27. Rodrigo R, Cauli O, Gomez-Pinedo U, Agusti A, Hernandez-Rabaza V, Garcia-Verdugo JM, Felipo V (2010) Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 139(2):675-684